Table 3 Median and 95% credible intervals for all model parameters for each treatment group

From: Modelling microbiome recovery after antibiotics using a stability landscape framework

   D A Phi1 Phi2
Microbiome Antibiotic Median 95% CI Median 95% CI Median 95% CI Median 95% CI
Gut Ciprofloxacin 7.9 (5.47 to 9.75) 0.8 (0.28 to 1.34) −0.2 (−0.69 to 0.16) 0.41 (0.05 to 0.92)
Clindamycin 8.45 (6.23 to 9.84) 0.84 (0.29 to 1.42) 0 (−0.46 to 0.34) 0.56 (0.23 to 1.11)
Amoxicillin 1.34 (0.13 to 6.56) −0.03 (−0.66 to 0.56) −1.53 (−1.96 to 0.31) 0.09 (−1.58 to 1.83)
Minocycline 2.74 (1.54 to 7.82) −0.23 (−1.09 to 0.23) 0.33 (−1.44 to 1.29) 1.65 (1.01 to 1.97)
Oral Ciprofloxacin 2.99 (1.86 to 5.23) −0.63 (−1.21 to 0.19) 0.19 (−0.85 to 0.96) 1.56 (0.84 to –1.96)
Clindamycin 3.56 (2.33 to 5.77) −0.73 (−1.44 to 0.14) 0.66 (−0.33 to 1.37) 1.61 (1.02 to 1.96)
Amoxicillin 4.24 (0.41 to 9.26) −0.13 (−1.01 to 0.71) −1.58 (−1.96 to 0.46) −0.33 (−1.45 to 1.69)
Minocycline 3.38 (0.70 to 8.85) 0.53 (−0.50 to 1.55) −0.73 (−1.87 to 1.19) 1.27 (−0.63 to 1.94)
  1. Results from Bayesian fitting of the full model (model 2, Eq. 4) to each of the eight possible treatment groups (four antibiotics × two microbiomes)